Who
Brent Hatzis-Schoch
Officer
Company insider
Files Form 4 as: Officer, Black Diamond Therapeutics; Sr. VP, General Counsel, Radius Health.
In numbers
- Trades disclosed
- 60
- Buys
- 2
- Sells
- 9
- Bought
- $107K
- Sold
- $1.4M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 10 Feb 2016
- Last trade
- 21 Jan 2026
- Last filed
- 23 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Jan 2026filed 23 Jan 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 30 Jan 2025filed 31 Jan 2025 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 30 Jan 2025filed 31 Jan 2025 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 14 Feb 2024filed 15 Feb 2024 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 13 Feb 2023filed 15 Feb 2023 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 15 Feb 2022filed 17 Feb 2022 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 12 May 2021filed 13 May 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $13K4,078 at $3.20 | filing |
| 12 May 2021filed 13 May 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $30K1,161 at $26.11 | filing |
| 12 May 2021filed 13 May 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $72K2,566 at $27.90 | filing |
| 12 May 2021filed 13 May 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,898351 at $28.20 | filing |
| 12 May 2021filed 13 May 2021 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,078 at $0.00 | filing |
| 12 Apr 2021filed 13 Apr 2021 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —179,915 at $0.00 | filing |
| 12 Apr 2021filed 13 Apr 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $13K4,078 at $3.20 | filing |
| 12 Apr 2021filed 13 Apr 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $102K4,078 at $25.00 | filing |
| 12 Mar 2021filed 16 Mar 2021 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,078 at $0.00 | filing |
| 12 Mar 2021filed 16 Mar 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $13K4,078 at $3.20 | filing |
| 12 Mar 2021filed 16 Mar 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Sold | $107K4,078 at $26.36 | filing |
| 17 Feb 2021filed 19 Feb 2021 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 12 Feb 2021filed 12 Feb 2021 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code M | $13K4,078 at $3.20 | filing |
News
Reviewing Black Diamond Therapeutics (NASDAQ:BDTX) & Sera Prognostics (NASDAQ:SERA)BDTX · tickerreport.com · 22 Oct 2026Comparing Black Diamond Therapeutics (NASDAQ:BDTX) & Entrada Therapeutics (NASDAQ:TRDA)BDTX · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Brent Hatzis-Schoch; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.